Skip to main content

Table 3 Association between each predictor and outcome from the SI dataset

From: Development of a prognostic model for 1-year survival after fragile hip fracture in Chinese

Characteristic

Patients with an outcome (n = 68)

Patients without an outcome (n = 667)

Univariate hazard ratios (95% CI)

Full model hazard ratios(95%CI)

LASSO model hazard ratios(95%CI)

Demographic characteristics

Age (years) (82 vs. 68)

80 (SD 7.9)

74 (SD 9.5)

2.7 (1.8, 4.0)

2.2 (1.4, 3.5)

1.8 (1.2, 2.8)

Sex (Female = 0, Male = 1, 1 vs. 0)

35 (51.5%) (Male)

244 (36.6%) (Male)

1.7 (1.1, 2.8)

1.7 (1.0, 2.8)

1.4 (0.8, 2.2)

Medical history

MLA (No = 0, Yes = 1, 1 vs. 0)

5 (7.4%) (Yes)

13 (1.9%) (Yes)

3.2 (1.3, 7.9)

4.1 (1.4, 11.9)

2.7 (1.0, 7.7)

LD (No = 0, Yes = 1, 1 vs. 0)

34 (50.0%) (Yes)

266 (39.9%) (Yes)

1.5 (1.0, 2.5)

1.0 (0.6, 1.7)

-

ALI (No = 0, Yes = 1, 0 vs. 1)

15 (22.1%) (No)

92 (13.8%) (No)

1.7 (0.9, 3.0)

1.5 (0.8, 2.9)

1.3 (0.7, 2.5)

CCD (No = 0, Yes = 1, 1 vs. 0)

37 (54.4%) (Yes)

258 (38.7%) (Yes)

1.8 (1.1, 3.0)

1.5 (0.9, 2.6)

1.4 (0.8, 2.4)

HYP (No = 0, Yes = 1, 1 vs. 0)

34 (50.0%) (Yes)

323 (48.4%) (Yes)

1.1 (0.7, 1.7)

1.5 (0.8, 2.5)

1.2 (0.7, 2.0)

Clinical indicators

BS (mmol/L) (7.1 vs. 5.5)

6.9 (SD 2.7)

6.8 (SD 2.3)

1.0 (0.9, 1.2)

1.1 (0.9, 1.2)

–

SC (μmol/L) (79 vs. 56)

80.1 (SD 32.2)

69.2 (SD 22.5)

1.3 (1.1, 1.6)

1.2 (1.0, 1.5)

1.2 (1.0, 1.4)

ALB(g/L) (40.8 vs. 35.3)

35.1 (SD 4.3)

38.1 (SD 4.0)

0.4 (0.3, 0.6)

0.6 (0.4, 0.8)

0.6 (0.5, 0.9)

Hb(g/L) (132 vs. 104)

111.2 (SD 23.3)

118.4 (SD 19.6)

0.6 (0.5, 0.9)

1.1 (0.7, 1.5)

–

Treatment

SUR (No = 0, Yes = 1, 0 vs. 1)

30 (44.1%) (No)

59 (8.8%) (No)

6.9 (4.3, 11.2)

5.2 (3.1, 8.7)

4.8 (2.9, 8.0)

  1. SD: standard deviation; CI: confidence interval